Next 10 |
home / stock / cor / cor articles
Koninklijke Philips (NYSE: PHG) recently announced the receipt of FDA 510(k) approval for its Zenition 30 mobile C-arm. The approval is likely to m...
Disclosed in a recent SEC filing on April 17, Collis, Chairman at Cencora (NYSE:COR), made a noteworthy transaction involving the exercise of compa...
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 3.55% on an annualized basis producing an average annual return of 13.93%....
Cencora (NYSE:COR) has outperformed the market over the past 5 years by 13.84% on an annualized basis producing an average annual return of 26.68%....
Revealing a significant insider sell on March 20, Elizabeth S Campbell, Executive Vice President at Cencora (NYSE:COR), as per the latest SEC filin...
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 2.6% on an annualized basis producing an average annual return of 13.25%. ...
Cencora (NYSE:COR) has outperformed the market over the past 5 years by 11.43% on an annualized basis producing an average annual return of 24.09%....
The Federal Trade Commission (FTC) is reportedly launching an investigation into recent shortages of chemotherapies, including carboplatin, cisplat...
Walgreens Boots Alliance Inc, 10% Owner at Cencora (NYSE:COR), executed a substantial insider sell on February 9, according to an SEC filing. What ...
News, Short Squeeze, Breakout and More Instantly...
CoreSite Realty Corporation Company Name:
COR Stock Symbol:
NYSE Market:
Koninklijke Philips (NYSE: PHG) recently announced the receipt of FDA 510(k) approval for its Zenition 30 mobile C-arm. The approval is likely to m...
Disclosed in a recent SEC filing on April 17, Collis, Chairman at Cencora (NYSE:COR), made a noteworthy transaction involving the exercise of compa...